Status:

COMPLETED

Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor

Lead Sponsor:

Ohio State University

Conditions:

Preeclampsia Severe

Eligibility:

FEMALE

18-45 years

Phase:

PHASE4

Brief Summary

This is a randomized double blind placebo controlled trial comparing Nifedipine 30mg XL to placebo in 110 patients after decision has been made to proceed with induction of labor for the diagnosis of ...

Detailed Description

This is a randomized double blind placebo controlled trial comparing Nifedipine 30mg XL to placebo in 110 patients after decision has been made to proceed with induction of labor for the diagnosis of ...

Eligibility Criteria

Inclusion

  • Women aged 18-45 with a viable single or twin intrauterine pregnancy between 22 0/7 and 41 6/7 weeks gestation based on the best obstetric estimate by The American College of Obstetricians and Gynecologists (ACOG) criteria.
  • Diagnosis of preeclampsia with severe features with decision made to induce labor. The patient may or may not have already received acute treatment for severe blood pressures.

Exclusion

  • Known allergy or adverse reaction to Nifedipine or any medical condition where Nifedipine is contraindicated, such as galactose intolerance, severe gastrointestinal (GI) structure, and GI hypomotility disorder.
  • Currently receiving Nifedipine XL as part of hypertension management prior to induction of labor
  • Participation in another trial that affects the primary outcome without prior approval
  • Physician/provider or patient refusal
  • Participation in this trial in a prior pregnancy
  • Triplet or higher order pregnancy

Key Trial Info

Start Date :

June 9 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 10 2022

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT04392375

Start Date

June 9 2020

End Date

May 10 2022

Last Update

July 24 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine

Columbus, Ohio, United States, 43210